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There  are  increasing  clinical  (1-6),  functional  (7),  radiological  (4,  5,  6,  8),  and 
histological  (3,  9-14)  evidences  that  interstitial  pneumonitis  with  or  without  pul- 
monary fibrosis may develop in patients with underlying diseases which appear to be 
associated  with  circulating antigen-antibody  complexes.  The pathogenesis of  these 
human lesions, however, has not been studied  in experimental animal models. Rabbits 
with acute or chronic  serum  sickness  have not  shown  pulmonary changes  (15, 16). 
On the other hand, acute anaphylactic shock, a condition  characterized by preferential 
precipitation  of  circulating  antigen-antibody  complexes  within  the  lumina  of  pul- 
monary capillaries  (17-19),  is caused by a mechanism which has no relationship with 
chronic pulmonary diseases in man. 
These  considerations  have  suggested  the  possibility that  antigen-antibody  com- 
plexes present in large amount and for prolonged  periods  of time in the circulation of 
rabbits may localize in  their lungs,  thereby producing inflammatory reactions com- 
parable to those commonly seen in the kidneys of the same animals. 
The results of the studies described here show that rabbits making a hyper- 
active antibody response to injections of bovine serum albumin (BSA), 1 when 
maintained  in  a  state  of  relative  antigen-antibody  equivalence  by  high, 
multiple, daily doses of BSA, develop membranous and/or proliferative lesions 
of the lung which are associated with deposition of antigen, host immunoglobu- 
lin,  complement,  and  fibrinogen  in  pulmonary structures.  The  inflammatory 
changes,  which  are  presumably  produced  by  antigen-antibody  complexes, 
cover  the  morphologic  spectrum  of  certain  human  interstitial  pneumonitis 
(20,  21). 
Materials and Methods 
Induction  of Serum Sickness.--58  female albino rabbits weighing 2-3 kg were purchased 
from a local breeder, and fed Purina rabbit pellets and water ad libitum. 51 rabbits were used 
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02357 and AM-13200 and from Grant 91271 of the New York Society for Kidney Diseases. 
:~ Recipient of Fellowships of the American National Kidney Foundation and the Bertha 
and  Henry Buswell Fund. 
1  Abbreviations used in this paper:  BSA, bovine serum albumin; H  & E,  hemotoxylin and 
eosin; PAS, periodic acid-Schiff; Rb, rabbit. 
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for immunization and seven as untreated controls. Crystallized BSA (Armor Pharmaceutical 
Company,  Kankakee,  Ill.), diluted  in physiologic saline to  2.5  mg/ml, was injected intra- 
venously daily. The doses of antigen given to different rabbits were varied according to the 
procedure described by Dixon, Feldman, and Vazquez (15) in an attempt to match the anti- 
body response and thereby to keep the ratio of antigen to antibody in the circulation near 
equivalence or in slight antigen excess. The initial dose was  12.5 mg/day.  In order to neu- 
tralize all the antibody elaborated in animals with best response, daily doses up to 150 mg of 
antigen were required.  Since a  single  injection of such amount  of BSA frequently provoked 
anaphylactic symptoms or fatal anaphylaxis, a daily dose higher than 50 mg was divided into 
two equal portions slowly injected at intervals of 2-8 hours.  Furthermore this procedure of 
multiple injections was adopted also because it might allow the formation of larger amounts 
and  longer persistence  of immune complexes in the circulation than  in rabbits  receiving a 
single daily injection (15, 22). With such type of immunization anaphylactic symptoms were 
prevented and the best responders could be included in this study. All rabbits were bled weekly 
18-24 h after a  BSA injection. The quantities of antigen and/or antibody in the circulation 
were determined by capillary precipitin test. Two or three times a week, the 24-h urine output 
was collected from each rabbit  and the presence of proteinuria and  hematuria  determined. 
Urinary protein was  measured  according to the  method  of Shevky and  Stafford  (23)  and 
hematuria  was  detected  by Labstix  (Ames  Company,  Elkhart,  Ind.).  Blood urea  nitrogen 
concentration was measured every 2 wk or more frequently if animals developed oliguria and 
renal failure. Rabbits were sacrificed by exsanguination under sodium pentobarbital anesthesia 
at  different intervals of time, and  lungs and  kidneys were examined by morphological and 
immunohistochemical techniques.  In some rabbits,  which showed a  progressive decrease of 
antibody titer, the injection of antigen was discontinued. 
Preparation of Tissues for  Histological Studies.--Lungs  and  kidneys  were  removed and 
weighed. Part of each specimen was fixed in 10% buffered formalin and embedded in paraffin. 
Sections were stained with hemotoxylin and eosin (H & E), periodic acid-Schiff (PAS) reagent, 
silver-methenamine  (Jones),  and  Masson  trichrome.  Another portion  of the  specimen was 
fixed in a mixture of paraformaldehyde and glutaraldehyde  (24) postfixed in osmium tetroxide 
and embedded in Epon 812. Sections cut at 1/z were stained with toluidine blue and examined 
by light microscopy. Sections for electron microscopy were cut with an LKB Ultratome  (LKB 
Instruments,  Inc.,  Rockville,  Md.)  and  examined  with  Siemens  101  Electron  Microscope 
(Siemens Corp., Medical Industrial  Div., Iselin, N. J.). 
Immunohistologlcal Techniques.--The  globulin fractions  of antisera  to  BSA, pneumono- 
coccus Type II, rat  globulin,  rabbit IgG (Hyland Div., Travenol Laboratories, Costa Mesa, 
Calif), rabbit  fibrinogen,  and  rabbit  albumin  (Cappel Laboratories,  Inc., Downington,  Pa.) 
were separated  and  conjugated with fluorescein  or ferritin as described elsewhere  (25, 26). 
The antiserum to rabbit  C3, which was used for immunoelectron microscopy, was a  gift of 
Dr.  Charles  G.  Corchrane.  The antiserum to rabbit  C3, used for immunofluorescence, was 
purchased from Cappel Laboratories. The staining of specimens and the control experiments 
were performed as described in a previous publication (27). The sections were viewed with a 
Leitz Ortholux microscope (E. Leitz, Inc., Rockleigh, N. J.) equipped with a Ploem fluorescence 
illuminator. The intensity and extent of fluorescence was arbitrarily graded as 0, negative; -¢-, 
minimal; 1+, slight; 2+, moderate; and 3+, marked. 
RESULTS 
The  findings  described  here  were  obtained  from  58  rabbits  studied  for  a 
period of 2-33  wk. On the basis  of immunologic response  the animals  injected 
with BSA for prolonged period of time were divided into three groups. 
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rise of antibody titer after 2-3 wk of immunization. This required an increase in 
the amount of BSA injected in order to maintain a state of relative equivalence. 
In 14 of these rabbits a plateau of 100-150 mg of BSA/day was reached and in 
most of them  there  was  little variation in  the  amount of antigen required. 
Antibody production remained high for variable periods of time but in some 
rabbits eventually declined (Rb 48, 45, 20, 21). 13 of these rabbits (Rb 7, 15, 52, 
65, 23, 28, 35, 37, 73, 17, 24, 81, 91) developed membranous and/or proliferative 
pulmonary lesions,  together with glomerulonephritis and marked proteinuria. 
The maximum dose of BSA during immunization, the dose at time of sacrifice, 
the duration of immunization and that of proteinuria, the level of BUN at time 
of sacrifice,  and the immunofluorescence and morphologic findings of the lung 
are given in Table I. Fig. 1 shows the course of experiment in a rabbit (Rb 15) 
with high antibody response. 
In the majority of these rabbits the gross feature of the lung was normal. In 
Rb  15, 35,  and 73  the lungs were enlarged, with small or large hemorrhages 
beneath the pleura (Fig. 2). The cut surface was edematous or congested and 
areas of hepatization were present. 
Morphologically the pulmonary changes developing in  the  rabbits  of this 
group were membranous and/or proliferative. In two rabbits  (Rb  15  and  73) 
thickening of alveolar capillary walls was seen without marked proliferation 
(Fig. 3). This lesion resembled the changes of idiopathic membranous nephrop- 
TABLE  I 
Dose of BSA, Functional  and Immunohistological  Findings in the Lungs  of Group I  Rabbits 
BSA  Proteinuria  Lung 
Dura-  Dura.  BUN 
At  tion  tion  at  Fluorescence-microscopy 
•  Light-  Elec- 
Rb  Marl-  time  immuni-  ex-  Dura-  At time  time  Rabbit  Rab-  micros-  mtr°ns_ 
no.  mum  sacri-  zation  peri-  tion  sacrifice  rice  BSA  IgG  bit C3  gen  bumin  copy  dose  rice  ment  saen-  Rabbit  Rab-  fibrino-  bit al-  copy 
rag~day  wk  wk  wk  rag%  rag% 
7  150  1so  14  14  4  850  40  ++  ++  +  0  +  +++  +++ 
15  150  150  10  10  4  800  231  +++  +++  ±  ++  0  ++  +++ 
52  150  150  7  7  2  700  130  +++  +++  0  ±  0  ~  ++ 
64  150  150  8  8  2.5  770  56  0  0  0  0  0  +  =k 
65  150  150  10  10  3  700  46  ±  ±  0  0  0  ±  -.J-q- 
23  100  100  7  7  2  800  96  +++  +++  ±  +++  0  +  +++ 
28  100  100  8  8  3  650  65  "4-+  -'}-  -~"  0  "4-+  0  ++  +-{-3  t- 
35  100  100  7  7  1  650  92  +++  +++  0  ++  0  +++  +++ 
37  100  100  10  10  3  700  33  +++  +++  0  +  0  +  +++ 
73  100  100  12  12  3  1,050  165  +++  +++  0  0  0  ++  +++ 
17  100  50  12  12  5  450  46  +++  +++  0  +  0  +  +++ 
24  75  75  8  8  2  700  s2  ++  ++  0  ++  0  ++  + 
82  50  50  11  11  2  820  264  -J-+  ++  ±  -4=  ±  ±  -- 
91  50  ,50  10  10  3  700  150  ++  ++  0  +  0  +  ++ 
48  150  0  15  27  6  40  26  0  0  0  0  0  4-  -4- 
45  100  0  15  26  7  30  23  0  ±  0  0  0  ±  + 
20  100  0  10  33  5  50  18  0  0  0  0  0  0  0 
21  50  0  8  32  4  30  16  0  0  0  -4-  0  ±  0 
Abbreviations: O, negative; --, not tested; ±, minimal amount; +, a  slight amount; ++,  moderate amount; +++, 
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FIG. 1.  Rb 15, injected with BSA for 70 days. In order to match antibody production, the 
antigen dose was increased up to 150 mg/day. Proteinuria started 43 days and renal failure 
58  days  after  beginning of  immunization. At  sacrifice the  rabbit  showed membranous 
pneumonitis. 
athy or those of membranous systemic lupus erythematosus glomerulonephritis. 
More commonly, however, the thickening of capillary walls was associated with 
proliferation of septal cells, increase of PAS-positive material in the interstitium, 
accumulation  of polymorphonuclear leukocytes in  capillaries  with  partial  or 
complete obliteration of their lumina (Figs. 4, 5, 6), and alveolar hemorrhages. 
These changes produced a marked thickening and distortion of alveolar septa. 
By electron microscopy the most characteristic finding was represented by 
deposits of electron-opaque material in the walls of alveolar capillaries and in 
the  interstitium.  In  the  capillaries  the  deposits  were  mainly  subendothelial, 
The membranous thickening of alveolar capillary wall, seen by light microscopy. 
was produced by extensive accumulation of deposits between the endothelium 
and the alveolar basement membrane (Figs. 7, 8). Only rare focal subepithelial 
deposits,  comparable to  the  glomerular "humps",  were seen in rabbits  with BRENTJENS,  O'CONNELL,  PAWLOWSKI,  HSU~ AND  ANDRES  109 
Fro.  2.  Lungs of rabbit 73.  Hemorrhagic areas are seen at the parenchymal surface. 
marked  proliferative  lesions  (Fig.  9).  Likewise,  interstitial  deposits  were  ob- 
served mainly in animals with proliferative pneumonitis. 
The alveolar capillary walls, the interstitium,  and the walls of the terminal 
bronchioles contained deposits of BSA (Figs.  10,  12) and rabbit IgG (Fig.  11). 
The  staining  pattern  obtained  with  respective  specific fluorescein-conjugated 
antisera was similar,  i.e.,  uniformly distributed along capillary walls and inter- 
stitium  in form of discrete granular  deposits, corresponding  to the position of 
the electron-opaque aggregates seen by electron microscopy. Demonstration  of 
deposits  of C3 in  the  lung  was not  readily  achieved  by immunofluorescence. 
Staining of lung tissues with fluorescein-conjugated antibody to rabbit albumin 
was consistently negative. 
The experiments of immunoelectron microscopy confirmed that the electron- 
opaque deposits indeed contained BSA and rabbit IgG. However, specific bind- 
ing  of ferritin-conjugated  antibody  to  C3  was  also observed  in  the  deposits. 
Fig.  13 shows a section through  a lung capillary wall of Rb 35. The basement 
membrane  and  the  subendothelial  deposits  are  tagged  by ferritin-conjugated 
antibody  to  BSA.  Fig.  14  illustrates  the  localization  of  ferritin-conjugated 
antibody to rabbit C~ in the subendothelial electron-opaque deposits and in the 
basement membrane.  Controls  for the foregoing experiments  were carried  out 
on fragments of lung from normal rabbits and rabbits with lung disease as fol- 
cows:  (a)  Fragments  of lung  from normal  rabbits  were  treated  with  ferritin- 
conjugated antibody to BSA or to rabbit globulin. There was no specific locali- 
zation of ferritin-conjugated  antibody. (b) Fragments of lung from rabbits with 
lhronic  serum sickness and pneumonitis  were treated  with ferritin-conjugated ]FIGS. 3-18 (with the exception of the inset of Fig. 3) illustrate pathologic aspects of pulmo- 
nary tissue from rabbits of Group I. 
FIG. 3.  Rb 15. The lumina of alveolar capillaries  (c) are patent. The arrow heads indicate 
membranous thickenings of alveolar capillary walls.  (a),  alveolar space. Silver-methenamine 
staining.  X  1,000. The inset shows a  normal alveolar septum of Rb 30.  Silver-methenamine 
staining X  1,000. 
FIC. 4.  Rb 7. Proliferative and exudative pneumonitis. H  & E stain. X  400. 
110 FIGS. 5 and 6.  Rb 7. The lumina of alveolar capillaries are  obliterated by proliferated cells 
and polymorphonuclear leukocytes. The arrows indicate some focal thickening of the capillary 
walls. (a), alveolar space; (m), alveolar macrophage. Toludine-Blue.  )< 1,600. 
FIG. 7.  This picture shows the boxed area of Fig. 8 at higher magnification. Some subendo- 
thelial electron-opaque deposits are indicated by arrows.(c), lumen of the alveolar capillary; 
(EN)  endothelial cell;  (a),  alveolar space;  (m),  part  of an alveolar macrophage;  (rbc),  red 
blood cell.  X  10,000. 
111 FIC. 8.  Rb 15. Membranous pneumonitis. Areas of increased electron-opacity (arrows)  are 
visible in  the  alveolar capillary  walls.  The  lumina  of the  capillaries  contain  erythrocytes 
(rbc),  a  polymorphonuclear  leukocyte  (Pmn)  and  two  mononuclear  cells  (N),  probably 
lymphocytes; (S), septal cells; (E), epithelial cell type 2;  (m), parts of alveolar macrophages; 
(a), alveolar space.  The boxed area is shown at  higher magnification in  Fig.  7.  X  4,000. 
112 FIa. 9.  Rb 7. The picture shows some aspects of proliferative and exudative pneumonitis. 
The  lumina of alveolar capillaries are  obliterated  by proliferated  cells  (N)  and  by a  poly- 
morphonuclear leukocyte (Pmn).  The thickness of the alveolar septum (its vertical axis runs 
from a to a) is greatly increased. The boxed area is seen, at higher magnification, in the lower 
part of the plate.  X  6,000.  The inset shows three focal subepithelial electron-opaque deposits 
(arrows).  X  14,000. 
113 FIG.  10.  Rb  15.  Sections of lung  stained  with  fluorescein-conjugated antibody  to  BSA. 
Granular deposits are seen along the alveolar capillary walls and in the interstitium. (c) lumina 
of alveolar capillaries;  (s),  lumen of an alveolar sac.  X  1,000. 
FIo.  ll.  Rb  15.  Section  of lung  stained  with  fluorescein-conjugated antibody  to  rabbit 
IgG. Granular deposits are present in the alveolar capillary walls and in the interstitium.  (a) 
alveolar space; (c)  lumina of alveolar capillaries;  (s)  alveolar sac.  X  1,000. 
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antibody to pneumonococcus Type II or to rat globulin. Fig. 15 illustrates the 
result of one of these experiments in which lung of Rb 35  was treated with 
ferritin-conjugated antibody to rat globulin. The electron-opaque deposits and 
the alveolar basement membrane do not contain ferritin granules. 
Fig. 16 shows that the interstitium of some rabbits with severe lesions con- 
tained precipitates of fibrinogen products. Fluorescein-conjugated antibody to 
rabbit  fibrinogen stained  the  interstitium and  some alveolar  capillary walls 
(Fig. 17). The fluorescence pattern was coarse and ribbon-like, therefore differ- 
ent from that of BSA and rabbit IgG. In these rabbits, fibrils with the periodic- 
ity of fibrin, progressive increase of interstitial collagen, interstitial sclerosis, 
and thickening of the basement membrane of alveolar capillaries (Fig. 18) were 
seen by electron microscopy. 
The study of the lungs of rabbits which received high doses of BSA (Rb 48, 
45, 20, 21) but in which antibody production progressively declined and BSA 
injections  were  discontinued,  showed  an  increased  amount  of  collagen  in 
alveolar septa. 
The second group (Group II)  consisted of  seven  rabbits  which  developed 
only a slight or moderate antibody response throughout the course of the  ex- 
periment. This antigen-antibody equivalence was maintained with low doses of 
BSA. Fig. 19 illustrates the course of one of these experiments. In four rabbits 
there was a progressive decline of the antibody response and eventually BSA 
administration was stopped.  Absence of pulmonary lesions  or slight  changes 
only were observed. Nevertheless all these animals developed proteinuria and a 
variable degree of glomerular changes. 
Ten rabbits  (Group III) failed to produce demonstrable precipitating anti- 
body. The animals were immunized for periods ranging from 5 to 15  wk and 
although the daily injection of BSA was maintained at the minimum level of 
12.5 rag/day, or less, there was permanent excess of antigen in the circulation. 
The lungs and the kidneys of these rabbits were consistently normal. 
Group IV included 16 rabbits which were sacrificed 10-19 days after begin- 
ning of immunization during acute serum sickness.  Acute serum sickness was 
characterized by the appearance of proteinuria, increase of BUN, and demon- 
stration of glomerular granular  deposits  of IgG,  Ca,  and  BSA  by immuno- 
fluorescence  microscopy  with  corresponding  focal  subepithelial  deposits  in 
glomerular capillary walls seen by electron microscopy. In some of these rabbits 
focal and granular deposits of BSA and host IgG were observed in the inter- 
stitium and capillary walls of the lung. The deposits were seen mainly within the 
cytoplasm of polymorphonuclear leukocytes. Areas of slight to moderate cellular 
infiltration  were  observed  by  light  microscopy.  The  studies  performed  by 
electron  microscopy  showed  infiltration  of  polymorphonuclear  leukocytes. 
They did not demonstrate, however,  electron-opaque  deposits  in  pulmonary 
structures.  Kidneys and  lungs  of noninjected rabbits  (Group  V)  were  con- 
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DISCUSSION 
The results of this study show that rabbits which make an hyperactive anti- 
body response to daily injections of BSA, when maintained in relative antigen- 
antibody equivalence by elevated doses of antigen, develop membranous and/or 
proliferative pneumonitis which is associated with deposition of BSA, host IgG, 
and fibrinogen in pulmonary structures. The granular pattern of fluorescence 
observed in the lung is comparable to that seen in renal glomeruli in immune 
complex disease and remarkably different from the linear staining characteristic 
of Goodpasture's syndrome (28,  29)  or experimental pneumonitis produced in 
rats  by  antilung  serum  (30,  31).  Immunoelectron microscopy confirms  that 
antigen,  immunoglobulin, presumably containing antibody to BSA, and com- 
plement are present in the electron-opaque deposits of the capillary walls and 
the interstitium.  It is therefore conceivable that these immunologic reactants 
form antigen-antibody complexes. Then, the lesions of the lung would result, 
like those of the renal glomeruli, from deposition of circulating immune com- 
plexes which have no immunologic relationship with the lung. The pulmonary 
structure,  the physicochemical characteristic of the  complexes as well as  the 
release of mediators  should have importance in  the  process of deposition in 
tissues (32). 
In previous studies of rabbits with chronic serum sickness extraglomerular 
lesions were not observed (15,  16, 22). The only extra-renal deposits of antigen 
found were in  the splenic  arterioles  although  there was  no morphologic ab- 
normality associated with this  deposition  (15). Therefore, the  most  probable 
explanation  for  the  development  of  pulmonary  lesions  in  rabbits  of Group 
I  is  that the different procedure of  immunization used  in  these  studies  may 
elicit  the  formation of larger  amount  of immune  complex  and/or  a  longer 
persistence of critical levels of complexes in  the circulation.  This  interpreta- 
tion is supported by the observation that deposition of BSA, rabbit IgG and 
C3, and lung changes comparable to those seen in Group I  were not present in 
rabbits of Groups II, III, IV and V, and in rabbits studied in previous experi- 
ments (15, 22). 
Immunization of rabbits with fractionated doses of antigen was adopted in 
order to avoid anaphylaxis and following the assumption that in patients with 
FIG. 12.  Rb  52.  Section of lung stained with fluorescein-conjugated  antibody to BSA. 
Granular deposits are seen in the wall of a terminal bronchiole. (l) lumen of the bronchiole; 
(EP), epithelium; (E), elastic tissue. X 1,000. The inset shows granular deposits of BSA along 
the alveolar capillary walls of Rb 15. (c) lumina of alveolar capillaries. )< 1,500. 
FIG. 13.  Rb 35. Alveolar  capillary walls from  tissue treated with ferritin-conjugated  anti- 
body to BSA. Several electron-opaque  deposits (arrows) are seen in the capillary walls. (c) 
lumina of capillaries; (a) alveolar space, >( 4,000. The inset shows an oblique section of the 
alveolar wall enclosed  in the boxed  area of Fig. 13, at higher magnification.  Ferritin is localized 
in the electron-opaque  deposits (d) and in the basement membrane (b). Some  ferritin granules 
are present also in the epithelial (E.P)  and endothelial (EN) cytoplasm. X 35,000. 118 BRENTJENS, O'CONNELL, PAWLOWSKI~ HSU, AND ANDRES  119 
systemic lupus erythematosus the release of DNA into  the circulation  can be 
envisioned as a slow and continuous process hardly reproducible by single daily 
intravenous  injection  of large  amount  of antigen  in  an  experimental  animal. 
With multiple injections of antigen the best antibody responders were included 
in this study and thus the percent of rabbits developing chronic serum sickness 
with high antigen intake was much greater than that  previously reported  by 
Dixon et al. (15)  and Andres et al. (22). 
Dixon, Feldman, and Vazquez (15)  have shown that in experimental immune 
complex  glomerulonephritis  the  critical  factor  determining  the  development 
of lesions is the quantity of antibody formed by rabbit. Furthermore, the same 
etiologic  and  pathogenetic  mechanisms may  produce  a  variety of  histologic 
lesions  resembling  the  spectrum  of human  glomerular  diseases.  Likewise,  in 
experimental immune complex disease of the lung the antibody response seems 
to be the critical factor since only rabbits with hyperactive responses develop 
pulmonary changes. Moreover the same etiologic and pathogenetic mechanism 
is  responsible  for  a  variety  of  membranous,  membranoproliferative,  or  pro- 
liferative pulmonary lesions that  appear to cover a  large spectrum  of human 
pathology. 
Much  remains  yet  to  be learned  about  human  lung  diseases  produced  by 
antigen-antibody complexes because the opportunity to view the development 
of pulmonary lesions  during  the  early stages  by biopsy is  rare.  The  present 
knowledge is based mainly on studies of tissues obtained at autopsy. The most 
comparable lesion is the "interstitial pneumonitis" which seems to be produced 
by an inflammatory process involving the supporting structures and the capil- 
laries  rather  than  the  alveoli.  Proliferation  of  interstitial  cells,  interstitial 
edema, accumulation of polymorphonuclear leukocytes  and  mononuclear cells 
with progressive increase of reticulin fibrils and of interstitial  fibrosis are con- 
sidered the basic elements of this disease (20, 21). 
It has been proposed that in rate instances  (sensitization  to Aspergillus fumigatus, 
coffee bean dust, inhalation of pituitary snuff, bird breeder's disease etc.) lung injury 
in man may be mediated by antigen-antibody complexes which are formed when the 
inhaled  antigen reacts with antibody at alveolar level, thereby producing an Arthus- 
Fla.  14.  Rb 17. Alveolar capillary wall from tissue treated with ferritin-conjugated anti- 
body to rabbit C3. The lumen (c) contains a polymorphonuclear  leukocyte (Pmn).  The arrows 
point to subendothelial electron-opaque deposits, d  indicates increased amount  of collagen 
in the interstitium.  X 4,000. The inset shows the part of the capillary wall enclosed in the 
boxed area at higher magnification. Ferritin is visible in the basement membrane (b) and in 
the electron-opaque deposits (arrows). Some  ferritin granules are also seen in the endothelium 
(EN) and in the epithelium (EP). (a), alveolar space; (c), capillary lumen. X 35,000. 
FIG. 15.  Rb 35.  Lung tissue treated  with ferritin-conjugated antibody  to rat  globulin. 
The picture shows an oblique section of an alveolar capillary containing subendothelial elec- 
tron-opaque deposits (arrow heads). Only a few ferritin granules (short arrows) are localized 
in the endothelium (EN). (EP),  epithelium; (a), alveolar space. X 35,000. FIG.  16.  The picture shows an alveolar septum of Rb 23.  The thickness  of the septum is 
increased  (vertical  axis from  a  to  a).  The  lumina  of the alveolar  capillaries  and  the  in- 
terstitium contain polymorphonuclear leukocytes (Pmn) and proliferated cells (N).  Deposits 
of fibrin (F) are visible in the interstitium.  X  10,000. 
120 Fro.  17.  Rb  23.  Section of  lung stained with fluorescein-conjugated antibody to  rabbit 
fibrinogen.  Fluorescent  deposits  are  seen  in  the  interstitium  (arrows)  and  along  alveolar 
capillary walls.  (c), lumina of alveolar capillaries; (a), alveolar space.  )<  1,000. 
Fro.  18.  The picture shows part of an alveolar capillary wall and of the interstitium in Rb 
23.  The thickness of the capillary wall is increased because organized material is present in 
the subendothelial space  (b).  The  lumen of the capillary  (c)  contains the remains of a  de- 
generated polymorphonuclear leukocyte. Collagen is visible in the interstitium (I).  (s), septal 
cell; (a), alveolar space.  X  14,000. 
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FIG. 19.  Rabbit  injected  with BSA for  126 days. This rabbit  produced  only moderate 
amount of antibody and received 12.5 mg of BSA/day.  Proteinuria  developed after 77 days 
of immunization. Level of BUN remained normal throughout  the course of the experiment. 
At sacrifice there was no evidence of pulmonary lesions. 
type  reaction  tentatively  defined  as  "extrinsic  allergic  alveolitis"  (33-35).  The hy- 
pothesis that pulmonary lesions  may also be elicited  by circulating antigen-antibody 
complexes has not been considered. 
Recent clinical,  histological, radiological, and functional studies,  however, suggest 
that  lung  disease  may be  associated  with  circulating  antigen-antibody  complexes. 
Hemophtisis and radiologic signs of lung infiltrates have been observed in patients with 
glomerulonephritis which appeared produced by circulating immune complexes (5, 6). 
Gamma globulin complexes with sedimentation rates ranging between 9 to 17 S, pre- 
sumably antigen-antibody complexes,  have been shown in the circulation of patients 
with idiopathic pulmonary fibrosis  (4).  In systemic lupus erythematosus, a disease  in 
which the pathogenetic role of circulating complexes has been firmly established (36), 
clinical (1, 2) as well as roentgenographic (8) evidence of pulmonary changes has been 
reported. Furthermore, in patients with lupus the measurement of pulmonary function 
has shown an impairment of diffusing capacity of the lung seemingly due to an increase 
of  membrane  resistance  (7).  Finally,  in  occasional  patients  with  systemic  lupus 
erythematosus pulmonary interstitial  fibrosis  (2,  3),  proliferative  alveolitis  (12,  13), 
interstitial  pneumonitis  (37),  pulmonary hemosiderosis  (9,  10),  classic  "wire  loop" 
changes  (11),  or subendothelial electron-opaque deposits in alveolar capillaries  (14) 
have been observed. It is likely that the routine use of lung biopsy in patients with 
underlying immune complex disease may contribute to define the pathogenetic role of 
circulating antigen-antibody complexes in pulmonary lesions in man. BRENTJENS, O'CONNELL, PAWLOWSKI, HSU, AND ANDRES  123 
SUMMARY 
Membranous and/or proliferative pneumonitis, similar in certain features to 
human interstitial pneumonitis, developed in rabbits making hyperactive anti- 
body response to daily injections of bovine serum albumin (BSA) administered 
in multiple large doses sufficient to maintain the state of relative antigen-anti- 
body equivalence. The pulmonary lesions were associated with deposition in 
alveolar capillary walls and interstitium of antigen, host globulin and comple- 
ment, presumably in immune complexes. In some rabbits  chronic interstitial 
pneumonitis, characterized by thickening of alveolar capillary walls,  interstitial 
fibrosis and deposition of fibrinogen, was observed. 
The production of immune  complex pneumonitis  seems  to  depend  on  the 
degree of the antibody response because rabbits developing chronic serum sick- 
ness  with  low doses of BSA,  rabbits  with  acute  serum  sickness  as  well  as 
nonresponders showed no pulmonary alterations. This observation is compar- 
able to that described by Dixon in his studies on experimental immune complex 
glomerulonephritis. It is conceivable that the pulmonary pathology shown here 
is  produced by formation of larger amounts of complexes which may persist 
longer at  critical  levels in  the  circulation than  in rabbits  immunized with  a 
single daily injection of BSA. 
In  conclusion  this  study  suggests:  first,  that  experimental  chronic  serum 
sickness can be used as a model, not only for glomerulonephritis, but also for 
experimental systemic disease,  comparable  to  human  systemic diseases  pro- 
duced by circulating antigen-antibody complexes; and second, that the patho- 
genesis proposed here offers an  alternative to using antilung basement mem- 
brane pneumonitis for the experimental approach to the study of human lung 
immunopathology. 
We thank Mrs. Soon Won Chai, Mrs. Catherine M. Schwegler, Mrs. Mary E. Holston, and 
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